Pulmonary hemodynamics in newborn piglets during hypoxemia and reoxygenation: blocking of the endothelin-1 receptors.
The effects of blocking endothelin (ET) receptors in pulmonary circulation during hypoxemia and reoxygenation were studied in five groups of piglets. Ten minutes before hypoxemia, the Hyp group (n = 10) was given saline and the 1-mg (n = 9) and 5-mg group (n = 9), respectively, were given 1 and 5 mg/kg i.v. SB 217242 (an ET receptor antagonist). Two groups served as normoxic controls. The piglets were ventilated with 8% O2 until base excess was <-20 mmol/L or mean arterial blood pressure was <20 mm Hg. Reoxygenation was performed with air. The increase of mean pulmonary artery pressure was significantly attenuated during hypoxemia and reoxygenation in the 1-mg group (p = 0.006). The pulmonary vascular resistance index increased significantly at the end of hypoxemia in the Hyp and 5-mg groups but was comparable to baseline in the 1-mg group. During the study period, the changes in pulmonary vascular resistance index were significantly attenuated in the 1-mg group compared with the 5-mg group. Stroke volume index was significantly attenuated compared with baseline in the 5-mg group during both hypoxemia and reoxygenation, whereas, in the Hyp and 1-mg group, stroke volume index was attenuated only at the end of hypoxemia. During hypoxemia, plasma ET-1 decreased from 1.9+/-0.2 to 1.3+/-0.3 ng/L (p = 0.008) in the Hyp group, remained unchanged in the 1-mg group, and increased from 1.6+/-0.2 to 6.6+/-1.6 ng/L (p = 0.008) in the 5-mg group. We conclude that blocking ET receptors attenuates pulmonary vasoconstriction during hypoxemia and reoxygenation in piglets.
Medbø
S
S
Department of Pediatric Research, Institute for Surgical Research, The National Hospital, Oslo, Norway.
Tølløfsrud
P A
PA
Saugstad
O D
OD
D000136:Acid-Base Equilibrium; D000704:Analysis of Variance; D000818:Animals; D000831:Animals, Newborn; D001784:Blood Gas Analysis; D002264:Carboxylic Acids / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D065128:Endothelin Receptor Antagonists; D006439:Hemodynamics / Q000502:physiology*; D000860:Hypoxia / Q000503:physiopathology*; D007189:Indans / Q000494:pharmacology; D010100:Oxygen / Q000097:blood*; D011652:Pulmonary Circulation / Q000502:physiology*; D044022:Receptor, Endothelin A; D013552:Swine
D002264:Carboxylic Acids; D065128:Endothelin Receptor Antagonists; D007189:Indans; D044022:Receptor, Endothelin A; C098288:enrasentan; D010100:Oxygen